$0.000001
At close: Jan 31, 1:35 PM EDT
Comments
Loading...
Molecule Holdings Analyst Ratings and Price Targets | OTC:EVRRF | Benzinga
Molecule Holdings Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Molecule Holdings Corp from these most-recent analyst ratings.
Analyst Ratings for Molecule Holdings
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Molecule Holdings (EVRRF) stock?
There is no price target for Molecule Holdings
What is the most recent analyst rating for Molecule Holdings (EVRRF)?
There is no analyst for Molecule Holdings
When was the last upgrade for Molecule Holdings (EVRRF)?
There is no last upgrade for Molecule Holdings
When was the last downgrade for Molecule Holdings (EVRRF)?
There is no last downgrade for Molecule Holdings.
When is the next analyst rating going to be posted or updated for Molecule Holdings (EVRRF)?
There is no next analyst rating for Molecule Holdings.
Is the Analyst Rating Molecule Holdings (EVRRF) correct?
There is no next analyst rating for Molecule Holdings.
Browse analyst ratings and price targets on all stocks.
